Bausch Health
346 hedge funds and large institutions have $5.61B invested in Bausch Health in 2016 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 112 increasing their positions, 119 reducing their positions, and 44 closing their positions.
24% more capital invested
Capital invested by funds: $4.51B → $5.61B (+$1.1B)
4% more funds holding in top 10
Funds holding in top 10: 23 → 24 (+1)
0.65% more ownership
Funds ownership: 65.07% → 65.72% (+0.65%)
0% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 44
0% less funds holding
Funds holding: 347 → 346 (-1)
6% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 119
15% less call options, than puts
Call options by funds: $1.16B | Put options by funds: $1.36B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$220M |
| 2 |
Morgan Stanley
New York
|
+$109M |
| 3 |
H
Hexavest
Montreal,
Quebec, Canada
|
+$51.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$49.8M |
| 5 |
O
OppenheimerFunds
New York
|
+$40.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$210M |
| 2 |
Barclays
London,
United Kingdom
|
-$88.4M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$53.4M |
| 4 |
SA
SQ Advisors
Naples,
Florida
|
-$48.9M |
| 5 |
Goldman Sachs
New York
|
-$41.5M |
BHC Hedge Fund Activity: Q3 2016 in Review
346 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2016, worth a combined $5.61B — up 24% from $4.51B a quarter earlier.
Fund positioning in BHC was balanced in Q3 2016: 44 funds opened new positions, 44 closed out, 112 added to existing stakes and 119 trimmed.
The largest buyer was PointState Capital, opening a new position worth an estimated $220M. The largest seller was Fidelity Investments, cutting an estimated $210M.
- 346 institutional investors held Bausch Health (BHC) as of Q3 2016, down from 347 in Q2 2016.
- Funds reported $5.61B of Bausch Health stock for Q3 2016, up 24% quarter-over-quarter.
- 44 funds opened new Bausch Health positions in Q3 2016 and 44 closed out, a net change of 0 holders.
- The largest Bausch Health buyer in Q3 2016 was PointState Capital, an estimated $220M added.
- The largest Bausch Health seller in Q3 2016 was Fidelity Investments, an estimated $210M sold.
Based on aggregated 13F filings for Q3 2016.